Your browser is out-of-date!

Update your browser to view this website correctly.

Disclaimer
To continue, please select your country of domicile and investor type. Depending on your domicile and the investor type that you select, you will have full or restricted access to the information due to legal reasons.

Retail clients: according to Art. 4 Abs. 2 FinSA

Professional/Institutional investors: according to Art. 4 paragraph 3-5 and Art. 5 paragraph 1 and 3-4 FinSA and Art. 10 paragraph 3 and 3ter CISA in conjunction with Art. 6a CISO

Important

Principles 

By using the website www.bellevuehealthcaretrust.com, you confirm that you have read, understood and accepted the general information provided by the Bellevue Group AG as well as these legal provisions. These may be subject to change and the use of the site may be restricted or terminated at any time without prior notice.

The information, products, data, services, tools and documents contained or described on this site ("website content") are for information purposes only and constitute neither an advertisement or recommendation nor an offer or solicitation (to buy) or redemption (sell) investment instruments, to effect any transaction or to enter into any legal relations.

The financial products mentioned on this site are not suitable for all investors. The information contained on this site does not constitute a financial, legal, fiscal or any other recommendation. Investment or other decisions should not be made solely on the basis of this document. In particular, you should not enter into any investment before you have read the corresponding fund agreement or legal prospectus, the annual and semi-annual reports, the articles of association (as far as they are applicable), as well as all other documents, as required in accordance with local legislation or the regulations applied in the legal jurisdictions or countries in which the corresponding investment fund has been licensed or approved for public offer or sale to the public.

In order to determine whether the investment in shares of a certain investment fund meets your specific requirements and matches your envisaged risks, we recommend that you contact an independent financial adviser. Furthermore, we recommend that you consult an independent tax adviser in order to obtain information on the tax regulations relating to a specific investment in your legal jurisdiction and with regard to your personal circumstances. In particular tax treatment depends on individual circumstances and may be subject to change.

PERFORMANCE

Past performance is not an indication or guarantee of the future performance of the investment. The value of investments may be subject to fluctuations and, under certain circumstances, investors may not get back the full amount invested. Changes in foreign-exchange rates may also cause the value of investments to go up or down.

For a full explanation of risks and the overall risk profile of financial products mentioned on this site, please refer to the relevant Key Investor Information Documents (KIDs) and Prospectuses.

DATA PROTECTION

By accessing this website you state that you agree with the data protection statement. If you do not agree with this statement you should refrain from accessing any further pages of this website. This statement may be updated at any time. We therefore recommend that you check this statement regularly.

CONFIRMATION

By clicking on "Accept", you confirm that you agree to the legal provisions. Alternatively, you can select "I don't accept" if you wish to leave the website

Welcome to our first update of 2025. Life under Trump 2.0 is<br />
proving to be as fast paced and uncertain as anyone could have<br />
reasonably imagined. The first salvos of a global trade war have<br />
been unleashed, and then partially retracted. Where we go from<br />
here is anyone’s guess. Is this the trade equivalent of gunboat<br />
diplomacy, Trump showing his actually a weak paper tiger or a<br />
return to 1930s economic orthodoxy? (We all know how the latter<br />
went).<br />
<br />
The impact of all of this on the healthcare sector is yet to be<br />
determined; supply chains are often longer and more complex than<br />
anyone realised before trying to unwind them. Yet, at the same<br />
time, there is a cogent argument for excluding such products of<br />
necessity (there again, food is quite essential, and it has not been<br />
excluded as yet). Even so, Trump has made specific comments<br />
about pharmaceutical production needing to ‘come home’.<br />
<br />
Whatever form they take, the economic impact of tariffs is bound<br />
to be negative overall; they are the antithesis of free trade. Prices<br />
will rise and discretionary demand will likely fall at the margin, as<br />
more goes toward food and financing costs. Defensive sectors may well offer a safe port in this storm, although healthcare must<br />
contend with inevitable changes to entitlement programmes like<br />
Medicaid and potentially RFK Jr too.

Bellevue Healthcare Trust Factsheet January 2025

Welcome to our first update of 2025. Life under Trump 2.0 is
proving to be as fast paced and uncertain as anyone could have
reasonably imagined. The first salvos of a global trade war have
been unleashed, and then partially retracted. Where we go from
here is anyone’s guess. Is this the trade equivalent of gunboat
diplomacy, Trump showing his actually a weak paper tiger or a
return to 1930s economic orthodoxy? (We all know how the latter
went).

The impact of all of this on the healthcare sector is yet to be
determined; supply chains are often longer and more complex than
anyone realised before trying to unwind them. Yet, at the same
time, there is a cogent argument for excluding such products of
necessity (there again, food is quite essential, and it has not been
excluded as yet). Even so, Trump has made specific comments
about pharmaceutical production needing to ‘come home’.

Whatever form they take, the economic impact of tariffs is bound
to be negative overall; they are the antithesis of free trade. Prices
will rise and discretionary demand will likely fall at the margin, as
more goes toward food and financing costs. Defensive sectors may well offer a safe port in this storm, although healthcare must
contend with inevitable changes to entitlement programmes like
Medicaid and potentially RFK Jr too.
06.02.2025